Structure Therapeutics (ADR)
Develops oral small-molecule medicines for metabolic, cardiovascular, and pulmonary conditions.
$47.37
After-hours close−0.10 (−0.21%)
At close$47.47(−3.56%)
| Date | Estimate | Reported | Surprise |
|---|---|---|---|
| Nov 2026 | −$0.32 | — | — |
| Aug 2026 | −$0.39 | −$0.49 | −25.6% |
| May 2026 | −$0.39 | −$0.35 | +10.3% |
| Feb 2026 | −$0.35 | −$0.49 | −40.0% |
| Nov 2025 | −$0.36 | −$0.37 | −2.8% |
The latest year is open to everyone — the 15 quarters behind it read with an account. Sign in | |||
| Aug 2025 | |||
| May 2025 | |||
| Feb 2025 | |||
| Nov 2024 | |||
| Aug 2024 | |||
| May 2024 | |||
| Mar 2024 | |||
| Nov 2023 | |||
| Aug 2023 | |||
| May 2023 | |||
| Mar 2023 | |||
| Sep 2022 | |||
| Jun 2022 | |||
| Mar 2022 | |||
| Dec 2021 | |||
| Report date | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise |
|---|---|---|---|---|---|---|
| Nov 5, 2026 | −$0.32 | — | — | $45.5M | — | — |
| Aug 6, 2026 | −$0.39 | −$0.49 | −25.6% | — | — | — |
| May 7, 2026 | −$0.39 | −$0.35 | +10.3% | $11.1M | — | — |
| Feb 26, 2026 | −$0.35 | −$0.49 | −40.0% | $9.2M | — | — |
| Nov 6, 2025 | −$0.36 | −$0.37 | −2.8% | — | — | — |
The latest year is open to everyone — the 15 quarters behind it read with an account. Sign in | ||||||
| Aug 6, 2025 | ||||||
| May 8, 2025 | ||||||
| Feb 27, 2025 | ||||||
| Nov 13, 2024 | ||||||
| Aug 8, 2024 | ||||||
| May 9, 2024 | ||||||
| Mar 8, 2024 | ||||||
| Nov 14, 2023 | ||||||
| Aug 10, 2023 | ||||||
| May 11, 2023 | ||||||
| Mar 31, 2023 | ||||||
| Sep 30, 2022 | ||||||
| Jun 30, 2022 | ||||||
| Mar 31, 2022 | ||||||
| Dec 31, 2021 | ||||||